NHS
-
Increase testing for genes linked to ovarian cancer – guidance
People who have an increased risk of carrying genes linked to ovarian cancer could be offered genetic testing on the NHS, it is announced today. Read more
-
NICE recommends first treatment for acute migraine
The NHS is to get its first low-cost drug for acute migraine in adults, heralding a “step-change in treatment”, it was announced today. Read more
-
Warning over undiagnosed hypertension
Many UK adults aged between 30 and 50 could be living with undiagnosed hypertension, it is claimed today. Read more
-
Project to target young adult type 2 diabetes
More than £14 million is to be allocated across England to create new teams focusing on care of type 2 diabetes in young adults, it has been announced. Read more
-
Emergency anaphylaxis guidance as hospital admissions rise
Guidance on how to recognise and respond to the signs of anaphylaxis has been repeated following a significant increase in hospital admissions. Read more
-
Healthcare access problems during COVID-19 linked to avoidable hospital admissions
People in England whose access to healthcare was disrupted during the COVID-19 pandemic were more likely to have potentially preventable hospital admissions, researchers report today. Read more
-
London measles risk as vaccines stay low
London is at risk of a major measles outbreak affecting tens of thousands of people, the UK Health Security Agency has warned. Read more
-
Dying patients’ needs often unmet in UK hospitals
People dying in UK hospitals without specialist palliative care input often have “significant and poorly identified unmet needs,” according to the first UK-wide evaluation of its kind, published today. Read more
-
AI speeding up radiotherapy preparation
A leading British hospital group has successfully applied artificial intelligence to clinical tasks aimed at cutting cancer care waiting times, it has been announced. Read more
-
Early promise for multi-cancer blood test
A multi-cancer blood test being trialled across the UK has shown significant promise in an early study, a global conference is to hear. Read more